de Man RA - Search Results

1

The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation.

van Zonneveld M, Flink HJ, Verhey E, Senturk H, Zeuzem S, Akarca US, Cakaloglu Y, Simon C, So TM, Gerken G, de Man RA, Hansen BE, Schalm SW, Janssen HL; HBV 99-01 Study Group. van Zonneveld M, et al. Among authors: de man ra. Aliment Pharmacol Ther. 2005 May 1;21(9):1163-71. doi: 10.1111/j.1365-2036.2005.02453.x. Aliment Pharmacol Ther. 2005. PMID: 15854180 Clinical Trial.

2

Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver.

de Jongh FE, Janssen HL, de Man RA, Hop WC, Schalm SW, van Blankenstein M. de Jongh FE, et al. Among authors: de man ra. Gastroenterology. 1992 Nov;103(5):1630-5. doi: 10.1016/0016-5085(92)91188-a. Gastroenterology. 1992. PMID: 1426884

3

Failure of acyclovir to enhance the antiviral effect of alpha lymphoblastoid interferon on HBe-seroconversion in chronic hepatitis B. A multi-centre randomized controlled trial.

Berk L, Schalm SW, de Man RA, Heytink RA, Berthelot P, Brechot C, Boboc B, Degos F, Marcellin P, Benhamou JP, et al. Berk L, et al. Among authors: de man ra. J Hepatol. 1992 Mar;14(2-3):305-9. doi: 10.1016/0168-8278(92)90175-o. J Hepatol. 1992. PMID: 1500694 Clinical Trial.

4

[Alpha-interferon antiviral treatment in 100 patients with chronic hepatitis B].

Janssen HL, Berk L, de Man RA, Heijtink RA, Schalm SW. Janssen HL, et al. Among authors: de man ra. Ned Tijdschr Geneeskd. 1992 Apr 25;136(17):835-9. Ned Tijdschr Geneeskd. 1992. PMID: 1522928 Dutch.

5

Treatment of chronic viral hepatitis.

de Man RA, Berk L, Schalm SW, Stijnen T. de Man RA, et al. Dig Dis. 1991;9(1):17-35. doi: 10.1159/000171290. Dig Dis. 1991. PMID: 1706968 Review. No abstract available.

6

Beneficial effects of Phyllanthus amarus for chronic hepatitis B, not confirmed.

Berk L, de Man RA, Schalm SW, Labadie RP, Heijtink RA. Berk L, et al. Among authors: de man ra. J Hepatol. 1991 May;12(3):405-6. doi: 10.1016/0168-8278(91)90850-b. J Hepatol. 1991. PMID: 1940272 Clinical Trial. No abstract available.

7

Phenprocoumon-induced hepatitis mimicking non-A, non-B hepatitis.

de Man RA, Wilson JH, Schalm SW, ten Kate FJ, van Leer E. de Man RA, et al. J Hepatol. 1990 Nov;11(3):318-21. doi: 10.1016/0168-8278(90)90214-c. J Hepatol. 1990. PMID: 1963177

8

Alpha lymphoblastoid interferon and acyclovir for chronic hepatitis delta.

Berk L, de Man RA, Housset C, Berthelot P, Schalm SW. Berk L, et al. Among authors: de man ra. Prog Clin Biol Res. 1991;364:411-20. Prog Clin Biol Res. 1991. PMID: 2020718

9

Selection of asymptomatic HIV carriers for antiviral therapy.

de Man RA, Schalm SW, Sprecher-Goldberger S, Stibbe J, van de Ende ME, Schrijnemakers P, Rothbarth PH. de Man RA, et al. Neth J Med. 1990 Oct;37(3-4):141-4. Neth J Med. 1990. PMID: 2250758

10

Improvement of hepatitis B-associated glomerulonephritis after antiviral combination therapy.

de Man RA, Schalm SW, van der Heijden AJ, ten Kate FW, Wolff ED, Heijtink RA. de Man RA, et al. J Hepatol. 1989 May;8(3):367-72. doi: 10.1016/0168-8278(89)90036-6. J Hepatol. 1989. PMID: 2471723

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

494 results

Search Page

Filters